Cargando…
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
Despite declining global malaria incidence, the disease continues to be a threat to people living in endemic regions. In 2015, an estimated 214 million new malaria cases and 438,000 deaths due to malaria were recorded. Plasmodium vivax is the second most common cause of malaria next to Plasmodium fa...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970641/ https://www.ncbi.nlm.nih.gov/pubmed/27528800 http://dx.doi.org/10.2147/DDDT.S61443 |